Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial.
Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ. Newby LK, et al. J Am Coll Cardiol. 1996 Mar 1;27(3):625-32. doi: 10.1016/0735-1097(95)00513-7. J Am Coll Cardiol. 1996. PMID: 8606274 Free article.
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M, Sketch MH Jr, Stebbins AL, DeFranco AC, Holmes DR Jr, Kleiman NS, Betriu A, Rutsch WR, Vahanian A, Topol EJ, Califf RM. Labinaz M, et al. Among authors: stebbins al. Am J Cardiol. 1996 Dec 15;78(12):1338-44. doi: 10.1016/s0002-9149(96)00654-6. Am J Cardiol. 1996. PMID: 8970403
Thrombolysis and Q wave versus non-Q wave first acute myocardial infarction: a GUSTO-I substudy. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries Investigators.
Barbagelata A, Califf RM, Sgarbossa EB, Goodman SG, Stebbins AL, Granger CB, Suarez LD, Borruel M, Gates K, Starr S, Wagner GS. Barbagelata A, et al. Among authors: stebbins al. J Am Coll Cardiol. 1997 Mar 15;29(4):770-7. doi: 10.1016/s0735-1097(96)00587-6. J Am Coll Cardiol. 1997. PMID: 9091523 Free article.
Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.
Berger PB, Holmes DR Jr, Stebbins AL, Bates ER, Califf RM, Topol EJ. Berger PB, et al. Among authors: stebbins al. Circulation. 1997 Jul 1;96(1):122-7. doi: 10.1161/01.cir.96.1.122. Circulation. 1997. PMID: 9236426 Clinical Trial.
Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM. Anderson RD, et al. Among authors: stebbins al. J Am Coll Cardiol. 1997 Sep;30(3):708-15. doi: 10.1016/s0735-1097(97)00227-1. J Am Coll Cardiol. 1997. PMID: 9283530 Free article. Clinical Trial.
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Mahaffey KW, Granger CB, Toth CA, White HD, Stebbins AL, Barbash GI, Vahanian A, Topol EJ, Califf RM. Mahaffey KW, et al. Among authors: stebbins al. J Am Coll Cardiol. 1997 Dec;30(7):1606-10. doi: 10.1016/s0735-1097(97)00394-x. J Am Coll Cardiol. 1997. PMID: 9385883 Free article. Clinical Trial.
Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries.
Betriu A, Califf RM, Bosch X, Guerci A, Stebbins AL, Barbagelata NA, Aylward PE, Vahanian A, Van de Werf F, Topol EJ. Betriu A, et al. Among authors: stebbins al. J Am Coll Cardiol. 1998 Jan;31(1):94-102. doi: 10.1016/s0735-1097(97)00428-2. J Am Coll Cardiol. 1998. PMID: 9426024 Free article.
113 results